| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 36 | 37 | 43 | 24 | | Cost of Revenue | 19 | 20 | 16 | 70 | | | Gross Profit | 16 | 16 | 27 | (46) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 134 | 150 | 199 | 113 | | Non Recurring |
-
|
-
|
-
| 1,225 | | Others | 10 | 26 | 5 | 109 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (128) | (160) | (177) | (1,493) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 0 | 0 | 0 | 268 | | Earnings Before Interest And Taxes | (128) | (160) | (177) | (1,226) | | Interest Expense | 0 | 0 | 0 | 6 | | Income Before Tax | (128) | (160) | (177) | (1,232) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (128) | (160) | (177) | (1,232) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (128) | (160) | (177) | (1,232) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($128) | ($160) | ($177) | ($1,232) |
|
0.31% Nasdaq 
0.05%
Income Statement
